P3 Health Partners (PIII) Cash from Financing Activities (2021 - 2025)

P3 Health Partners has reported Cash from Financing Activities for 5 years, with the latest figure at $12.9 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities fell 61.82% year-over-year to $12.9 million; the trailing twelve-month figure through Dec 2025 stood at $72.8 million (down 26.28% YoY), and the FY2025 full-year result was $72.8 million, down 26.28% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at $12.9 million, down from $14.7 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $87.2 million in Q2 2023, with the low at -$2.5 million in Q3 2024.
• Historically, Cash from Financing Activities has averaged $15.6 million across 5 years, with a median of $12.5 million in 2021.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities sank 5331.07% — and 2023, when it soared 7134.38%.
• P3 Health Partners' Cash from Financing Activities stood at -$22587.0 in 2021, then surged by 66509.88% to $15.0 million in 2022, then slumped by 105.6% to -$840000.0 in 2023, then surged by 4113.93% to $33.7 million in 2024, then tumbled by 61.82% to $12.9 million in 2025.
• The last three Cash from Financing Activities figures came in at $12.9 million (Q4 2025), $14.7 million (Q3 2025), and $14.6 million (Q2 2025), per Business Quant data.